For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Half Yearly Accounts 31 December 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Investor Presentation Half Year Results 31 Dec 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Nova Eye Completes $8m Placement
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Latest Events
See all
For Physicians
Combining a process of 360º pressurized viscodilation and catheterization, iTrack™ is a stent-free minimally invasive glaucoma surgery (MIGS) that is clinically proven to reduce intraocular pressure in glaucoma patients. It has also been observed to reduce patient reliance on glaucoma medications.
For Patients
A simple outpatient-based procedure, iTrack™ is a minimally invasive glaucoma surgery (MIGS) that can reduce the elevated intraocular pressure associated with glaucoma. It may also free you from the financial and lifestyle burdens of glaucoma medications.
Latest News
See allHalf Yearly Accounts 31 December 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Investor Presentation Half Year Results 31 Dec 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Nova Eye Completes $8m Placement
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023